2 reports

The drug candidate is a human immunoglobulin monoclonal antibody targeting eotaxin-##.

  • Allergy Drug
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Company

Anti-allergy Drug in Japan Bilanoa Tablets, an Oral Anti-allergy Drug in Japan TAIHO HAS FURTHER DEVELOPED THE DRUG AFTER SIGNING A LICENSE AGREEMENT WITH FAES FARMA IN JULY 2012 FOR THE DEVELOPMENT AND MARKETING RIGHTS IN JAPAN.

  • Acne Treatment
  • Allergy Drug
  • Dermatological Condition
  • Pharmaceutical
  • Company